<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02983669</url>
  </required_header>
  <id_info>
    <org_study_id>94-7648</org_study_id>
    <nct_id>NCT02983669</nct_id>
  </id_info>
  <brief_title>The Effects of Zataria Multiflora Boiss (Shirazi's Thyme) on Nonalcoholic Fatty Liver Disease</brief_title>
  <acronym>ThymeLiv</acronym>
  <official_title>The Effects of Zataria Multiflora Boiss (Shirazi's Thyme) on Biochemical Markers and Imaging Studies of Patients With Nonalcoholic Fatty Liver Disease (NAFLD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shiraz University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shiraz University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the effects and safety of a dietary supplement, Zataria
      multiflora Boiss (Shirazi's Thyme) in the treatment of non alcoholic fatty liver disease
      (NAFLD).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In a randomized double-blind placebo-controlled clinical trial Shirazi's Thyme is compared
      with placebo. Investigators select randomly 90 patients with NAFLD by inclusion criteria.
      Investigators measure anthropometric and laboratory parameters including fasting blood sugar,
      insulin, liver enzymes, lipid profile, and grade in sonography before intervention and 90
      days later. Patients are divided into two equal groups. Intervention group in addition to
      diet and exercise recommendations receive capsules containing 700 mg of Shirazi thyme powder
      daily for 90 days. Placebo group in addition to the same recommendations for diet and
      exercise, receives placebo capsules twice daily.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2017</start_date>
  <completion_date type="Actual">May 10, 2017</completion_date>
  <primary_completion_date type="Actual">April 20, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in ALT (Alanin aminotransferase) level</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in grade of fatty liver in sonography by use of Saverymuttu Scoring System</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in AST (Aspartate aminotransferase) level</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting blood sugar (FBS)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Gama GT (Î³-glutamyl transpeptidase) level</measure>
    <time_frame>3 monyhs</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting insulin level</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body weight</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist circumference</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hip circumference</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with adverse events</measure>
    <time_frame>4 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">86</enrollment>
  <condition>Fatty Liver</condition>
  <condition>Fatty Liver, Nonalcoholic</condition>
  <arm_group>
    <arm_group_label>Thyme</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Zataria multiflora Boiss powder capsule 350 mg twice daily for 3 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Wheat powder capsule 350 mg twice daily for 3 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Thyme</intervention_name>
    <description>Thyme capsule 350 mg twice daily</description>
    <arm_group_label>Thyme</arm_group_label>
    <other_name>Shirazi's Thyme</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo capsule 350 mg twice daily</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age: 20-65 years

          -  Body mass index: 18-35 kg/m2

          -  Serum ALT level: &gt;45 U/Lit. in Males, &gt;29 U/Lit. in Females

          -  Grade &gt;=1 fatty liver in liver sonography

        Exclusion Criteria:

          -  Pregnancy and Lactation

          -  Acute or chronic liver failure

          -  Acute or chronic renal failure

          -  Autoimmune or viral hepatitis

          -  Wilson's disease

          -  Diabetes mellitus

          -  Alcoholism

          -  Malignancy

          -  Hypothyroidism or hyperthyroidism

          -  Drug used in last three months: OCP, metformin, vitamin E, ursodeoxycholic acid,
             glucocorticoids, thiazolidenediones.

          -  History of allergic reactions to Thyme
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Majid Nimruzi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Research Center for Traditional Medicine &amp; History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mojtaba Heydari, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Research Center for Traditional Medicine &amp; History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nasrin dokht Zamani, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Research Center for Traditional Medicine &amp; History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Shahid Motahhari Clinic, Shiraz University of Medical Sciences</name>
      <address>
        <city>Shiraz</city>
        <state>Fars</state>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 2, 2016</study_first_submitted>
  <study_first_submitted_qc>December 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 6, 2016</study_first_posted>
  <last_update_submitted>October 3, 2017</last_update_submitted>
  <last_update_submitted_qc>October 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shiraz University of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Mesbah Shams, MD</investigator_full_name>
    <investigator_title>Associate professor of Internal medicine and Endocrinology</investigator_title>
  </responsible_party>
  <keyword>Thymus Plant</keyword>
  <keyword>Multiflotriol [Supplementary Concept]</keyword>
  <keyword>Zataria multiflora</keyword>
  <keyword>Complementary Therapies</keyword>
  <keyword>Herbal Medicine</keyword>
  <keyword>Medicine, traditional</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Fatty Liver</mesh_term>
    <mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

